相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Plasmid-based transient human stromal cell-derived factor-1 gene transfer improves cardiac function in chronic heart failure
S. Sundararaman et al.
GENE THERAPY (2011)
Cardiac gene therapy with SERCA2a: From bench to bedside
Judith K. Gwathmey et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2011)
Gene Therapy of mdx Mice With Large Truncated Dystrophins Generated by Recombination Using rAAV6
Guy L. Odom et al.
MOLECULAR THERAPY (2011)
Engineering Liver-detargeted AAV9 Vectors for Cardiac and Musculoskeletal Gene Transfer
Nagesh Pulicherla et al.
MOLECULAR THERAPY (2011)
A randomised, double-blind, placebo-controlled, multicentre study of the safety and efficacy of BIOBYPASS (AdGVVEGF121.10NH) gene therapy in patients with refractory advanced coronary artery disease: the NOVA trial
Jens Kastrup et al.
EUROINTERVENTION (2011)
Evidence for the Failure of Adeno-associated Virus Serotype 5 to Package a Viral Genome >= 8.2kb
Yi Lai et al.
MOLECULAR THERAPY (2010)
SERCA2a Gene Transfer Enhances eNOS Expression and Activity in Endothelial Cells
Lahouaria Hadri et al.
MOLECULAR THERAPY (2010)
Calcium Upregulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID Trial), a First-in-Human Phase 1/2 Clinical Trial
Brian E. Jaski et al.
JOURNAL OF CARDIAC FAILURE (2009)
Infectious Molecular Clones of Adeno-Associated Virus Isolated Directly from Human Tissues
Bruce C. Schnepp et al.
JOURNAL OF VIROLOGY (2009)
Evaluation of Vascular Delivery Methodologies to Enhance rAAV6-mediated Gene Transfer to Canine Striated Musculature
Paul Gregorevic et al.
MOLECULAR THERAPY (2009)
VEGF Gene Therapy Fails to Improve Perfusion of Ischemic Myocardium in Patients With Advanced Coronary Disease: Results of the NORTHERN Trial
Duncan J. Stewart et al.
MOLECULAR THERAPY (2009)
A myocardium tropic adeno-associated virus (AAV) evolved by DNA shuffling and in vivo selection
Lin Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Adeno-Associated Virus (AAV) Serotype 9 Provides Global Cardiac Gene Transfer Superior to AAV1, AAV6, AAV7, and AAV8 in the Mouse and Rat
Lawrence T. Bish et al.
HUMAN GENE THERAPY (2008)
Design of a phase 1/2 trial of intracoronary administration of AAV1/SERCA2a in patients with heart failure
Roger J. Hajjar et al.
JOURNAL OF CARDIAC FAILURE (2008)
Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction
James W. Yockman et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Lentiviral vector-mediated SERCA2 gene transfer protects against heart failure and left ventricular remodeling after myocardial infarction in rats
Kazuo Niwano et al.
MOLECULAR THERAPY (2008)
Percutaneous Transendocardial Delivery of Self-complementary Adeno-associated Virus 6 Achieves Global Cardiac Gene Transfer in Canines
Lawrence T. Bish et al.
MOLECULAR THERAPY (2008)
A Single Intravenous Injection of Adeno-associated Virus Serotype-9 Leads to Whole Body Skeletal Muscle Transduction in Dogs
Yongping Yue et al.
MOLECULAR THERAPY (2008)
Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection
Carmela Zincarelli et al.
MOLECULAR THERAPY (2008)
Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer
Bo Wu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
AAV serotype 1 mediates more efficient gene transfer to pig myocardium than AAV serotype 2 and plasmid
H. Su et al.
JOURNAL OF GENE MEDICINE (2008)
Cardio-specific long-term gene expression in a porcine model after selective pressure-regulated retroinfusion of adeno-associated viral (AAV) vectors
P. W. Raake et al.
GENE THERAPY (2008)
Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration
B. Bostick et al.
GENE THERAPY (2007)
Efficient whole-body transduction with trans-splicing adeno-associated viral vectors (vol 15, pg 750, 2007)
Arkasubhra Ghosh et al.
MOLECULAR THERAPY (2007)
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease:: a phase 2 randomized, controlled trial of AdVEGF121 (AdVEGF121) versus maximum medical treatment
D. J. Stewart et al.
GENE THERAPY (2006)
A randomized, double-blind, placebo-controlled, multicenter, pilot study of the safety and feasibility of catheter-based intramyocardial injection of AdVEGF121 in patients with refractory advanced coronary artery disease
Shmuel Fuchs et al.
CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2006)
Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo
Christina A. Pacak et al.
CIRCULATION RESEARCH (2006)
Robust systemic transduction with AAV9 vectors in mice: Efficient global cardiac gene transfer superior to that of AAV8
Katsuya Inagaki et al.
MOLECULAR THERAPY (2006)
Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology
J Alter et al.
NATURE MEDICINE (2006)
New recombinant serotypes of AAV vectors
GP Gao et al.
CURRENT GENE THERAPY (2005)
Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart
Z Wang et al.
NATURE BIOTECHNOLOGY (2005)
Myocardial gene transfer and long-term expression following intracoronary delivery of adeno-associated virus
BK Kaspar et al.
JOURNAL OF GENE MEDICINE (2005)
Systemic delivery of genes to striated muscles using adeno-associated viral vectors
P Gregorevic et al.
NATURE MEDICINE (2004)
Efficient and long-term intracardiac gene transfer in δ-sarcoglycan-deficiency hamster by adeno-associated virus-2 vectors
J Li et al.
GENE THERAPY (2003)
Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the mdx mouse heart
YP Yue et al.
CIRCULATION (2003)
One-year follow-up of direct myocardial gene transfer of vascular endothelial growth factor-2 using naked plasmid deoxyribonucleic acid by way of thoracotomy in no-option patients
FD Fortuin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2003)
Multiply attenuated, self-inactivating lentiviral vectors efficiently deliver and express genes for extended periods of time in adult rat cardiomyocytes in vivo
S Fleury et al.
CIRCULATION (2003)
Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo
J Zhao et al.
BASIC RESEARCH IN CARDIOLOGY (2002)
Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia
DW Losordo et al.
CIRCULATION (2002)
Restoration of deficient membrane proteins in the cardiomyopathic hamster by in vivo cardiac gene transfer
Y Ikeda et al.
CIRCULATION (2002)
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics
MA Kay et al.
NATURE MEDICINE (2001)
High-efficiency, long-term cardiac expression of foreign genes in living mouse embryos and neonates
G Christensen et al.
CIRCULATION (2000)
分享论文
